ESTEVE
About us

About us

Discover who we are, our values and our organization

 

ACTIVITIES

Pharmaceuticals

Commercial operations in human and veterinary health throughout the world.

Chemicals

Experience and quality in producing active ingredients and intermediates.

OUR COMMITMENTS

Sustainability

We focus on the economic balance and the social and environmental impact of our activities

Partnership

Commitment, reliability and sustainability characterize ESTEVE´s relationships with partners and guarantee outstanding results

ESTEVE IN 2 MINUTES

PRESS ROOM

MUNDIPHARMA AND PURDUE REACH A NEW DEAL TO IN-LICENCE FROM ESTEVE FULL GLOBAL RIGHTS AND DEVELOPMENT RESPONSIBILITIES FOR NOVEL FIRST-IN-CLASS SIGMA-1 ANTAGONIST (S1A OR MR309/E-52862)


17/05/2016 - Sigma-1 antagonism offers potential for a novel mechanism of action and first-in-class treatment for the management of pain.

Phase II study results on patients treated with S1A indicate an encouraging efficacy profile in the treatment of neuropathic pain and are awaiting publication.
...

» Go to Press Room

© 1996 - 2016 ESTEVE Privacy· Legal notice· Cookies policy· Help